reports
Abattis and Management Overcome Legal and Regulatory Allegations
Abattis and Management Overcome Legal and Regulatory Allegations After Over Two Years of Legal and Regulatory Battles, Abattis & its Management Receive Vindication VANCOUVER, British Columbia, March 19, 2021 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (“Abattis” or the “Company”) (OTC:ATTBF) is pleased to announce significant progress regarding its dealings with the British Columbia Securities Commission, the Class Action Lawsuit and its Operations. The Securities Commission On November 26, 2018, the British Columbia Securities Commission (the “BCSC”), issued a temporary order (the ...
Abattis Provides Update on Trading Halt and Corporate Developments
Abattis Provides Update on Trading Halt and Corporate Developments VANCOUVER, British Columbia, Nov. 08, 2019 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the “Company” or “Abattis“) (CSE:ATT) (OTC:ATTBF) announces the following updates on recent developments related to Abattis since the trading of the Company’s common shares on the Canadian Stock Exchange (the “CSE”) was halted on February 4, 2019 (the “Halt”). Regulatory Update Since the Halt, the Company filed its audited annual financial statements and management discussion and analysis on August 8, 2019. Following this, on Aug...
Abattis Announces Successful Closing of Pro Natura Acquisition
Abattis Announces Successful Closing of Pro Natura Acquisition VANCOUVER, British Columbia, May 21, 2019 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “Company" or "Abattis") (CSE:ATT) (OTC:ATTBF) is pleased to announce that, further to its news release dated April 2nd, 2019, the Company’s wholly-owned subsidiary, 1185277 B.C. Ltd. (the “Acquisition Subsidiary”) has successfully closed the acquisition (the “Acquisition”) of Pro Natura BV (“Pro Natura”). Company Newsletter Abattis is also pleased to announce that it will be relaunching its Company Newsletter (the “Newsletter”), whic...
Abattis Announces Resignation of Directors
Vancouver, British Columbia--(Newsfile Corp. - March 9, 2019) - Abattis Bioceuticals Corp (CSE: ATT) (OTC Pink: ATTBF) (the "Company" or "Abattis") announces that, effective February 20, 2019 and March 6, 2019, both Wolfgang Richter and James Irving have respectively resigned as directors of the Company.The Company thanks both Mr. Richter and Mr. Irving for their service and wishes each all the best in their future endeavors.About Abattis Bioceuticals Corp.Abattis is positioned to be a leader in the cannabis industry as a fully integrated medicinal cannabis company. The Company's flagship cul...
Abattis Provides Update on Conference Call
Abattis Provides Update on Conference Call VANCOUVER, British Columbia, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) provides the following update on the Company’s recent trading halt and upcoming conference call with Company management that was previously set for March 1, 2019. Update on Trading Halt Further to the Company’s news release dated February 18, 2019, trading of the Company’s common shares continues to be halted on the Canadian Securities Exchange until the Company files its financial statements for the year e...
Abattis Provides Update on Trading Halt and Announces Management Confe...
Abattis Provides Update on Trading Halt and Announces Management Conference Call VANCOUVER, British Columbia, Feb. 18, 2019 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to provide the following update on the Company’s recent trading halt and upcoming conference call with Company management set for March 1, 2019. Update on Trading Halt On February 4, 2019, the trading of the Company’s common shares was halted due to the Company’s failure to file its year-end financial statements within the 90 day filing deadline required unde...
Abattis Removed From BCSC Temporary Order
Abattis Removed From BCSC Temporary Order VANCOUVER, British Columbia, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce that the temporary order from the British Columbia Securities Commission (“BCSC”), issued on November 26, 2018 (the “Order”), has not been extended against Abattis. “Abattis is very happy with the BCSC’s decision to remove the Company from the Order such that Abattis can continue to focus its efforts on revenue generation and building shareholder value” stated Rob Abenante, President an...
Abattis Enters Into Definitive Share Exchange Agreement With NutriVida
Abattis Enters Into Definitive Share Exchange Agreement With NutriVida VANCOUVER, British Columbia, Jan. 10, 2019 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce that, further to its new release dated December 7, 2018, the Company has entered into a definitive share exchange agreement (the “Agreement”) with 1157016 B.C. Ltd., dba NutriVida, a private arm’s length company incorporated in the Province of British Columbia (“NutriVida”), pursuant to which the Company will acquire 100% of the issued and outstanding common ...
Abattis Provides Marketing and Operational Updates
Abattis Provides Marketing and Operational Updates VANCOUVER, British Columbia, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “Company" or "Abattis") (CSE:ATT) (OTC:ATTBF) is pleased to announce the launch of its new website and provide an operational update. Launch of New Marketing Materials Abattis has recently unveiled its new marketing and branding materials, developed in conjunction with media company Canada One Communications Inc. (“Canada One”). Marketing materials include an updated website, corporate presentation and conference materials all highlighting Abat...
Comfort Launch by Vergence Naturals Exceeds Expectations
Comfort Launch by Vergence Naturals Exceeds Expectations VANCOUVER, British Columbia, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to provide an update on the recent soft-launch of its cannabinoid-infused nutraceutical Comfort (“Comfort”) through the Company’s wholly-owned subsidiary, Vergence Naturals (“Vergence”), on Cyber-Monday, November 26, 2018. “The launch was an outstanding success,” according to Logistics Coordinator Mark Taylor of TandT Marketing. “Our goals for the soft launch were to test the orde...
Abattis to Display Products and Services at O’Cannabiz Conference on...
Abattis to Display Products and Services at O’Cannabiz Conference on December 10-11th, 2018 VANCOUVER, British Columbia, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce that the Company will be displaying a booth at the O’Cannabiz Conference and Expo taking place at Parq Casino in Vancouver, BC on December 10-11th, 2018 (“O’Cannabiz”). O’Cannabiz will address key cannabis investment themes, emerging opportunities in the developing Canadian market, as well as significant trends and developments in the ...
Abattis Announces Acquisition of Fertilizer Company NutriVida
Abattis Announces Acquisition of Fertilizer Company NutriVida VANCOUVER, British Columbia, Dec. 07, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce that it has signed a non-binding letter of intent dated December 6, 2018 (the “LOI”) to acquire 100% interest in NutriVida Corp. (“NutriVida”) through an arm’s length transaction, a privately held fertilizer and nutrient company located in Langley, BC. The acquisition of Nurtivida plays directly into the Company’s push to add to its current and future cannabis growt...
- Sid Rajeev
CRCUF CANARC RESOURCE CORP.
AI. ATRIUM MORTGAGE INVESTMENT CORP
AEM. AGNICO EAGLE MINES LIMITED
APHA APHRIA INC
DNG DYNACOR GOLD MINES INC.
7AZ1 ARIZONA GOLD CORP
YTY WI2WI CORP
0176 KRONOLOGI ASIA
ATTBF ABATTIS BIOCEUTICALS CORP
NCQ TRILOGY METALS INC
NYR NYRSTAR NV
TSN. TELSON RESOURCES INC
Abattis Comments on BCSC Temporary Order
Abattis Comments on BCSC Temporary Order VANCOUVER, British Columbia, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) comments on the news release regarding the British Columbia Securities Commission (“BCSC”) Temporary Order dated November 26, 2018. The BCSC issued a temporary order on Monday, November 26, 2018, which centers around share issuances by 11 CSE issuers to a very large group of consultants between February, 2018, and August, 2018. Abattis has been named as 1 of the 11 issuers as they have ongoing consulting ag...
- Sid Rajeev
Abattis Bioceuticals Celebrates Release of Comfort Through Vergence Na...
Abattis Bioceuticals Celebrates Release of Comfort Through Vergence Naturals VANCOUVER, British Columbia, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce the release of its first proprietary product, Comfort, through the Company’s wholly-owned subsidiary Vergence Naturals (“Vergence”). Comfort, a brand-new proprietary nutraceutical, which contains Alpinia Galangal and Capsicum Annuum, was developed by Abattis’ research scientists to activate the endocannabinoid system (“ECS”) and nourish endorphin relea...
Abattis Bioceuticals Acquires Proprietary Genetic Strain Bank
Abattis Bioceuticals Acquires Proprietary Genetic Strain Bank VANCOUVER, British Columbia, Nov. 23, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce that it has entered into a definitive agreement (the “Agreement”) to acquire 100% of Select Strains Inc. (“Select Strains”). Select Strains has almost two decades of experience within the cannabis space, specifically within the fields of cannabis testing, research, cultivation and optimization of proprietary seeds and strains. With a portfolio of over 140 laboratory-...
Abattis Retains Canadian and American Compliance Agency and Provides C...
Abattis Retains Canadian and American Compliance Agency and Provides Company Update VANCOUVER, British Columbia, Nov. 21, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce the appointment of Ingredient Identity LLC (“Ingredient Identity”), a Canadian and US regulatory and compliance agency, to assist the Company’s wholly-owned subsidiary, Vergence Naturals Ltd. (“Vergence Naturals”), with their ongoing Canadian and US regulatory compliance program. “Regulatory compliance is a cornerstone objective for Vergence...
Abattis Bioceuticals Announces Board Change
Vancouver, British Columbia--(Newsfile Corp. - October 19, 2018) - Abattis Bioceuticals Corp. (CSE: ATT) (OTC Pink: ATTBF) (the "Company" or "Abattis") is pleased to announce the additions of Kent McParland and Cedric Wilson to the Board of Directors (the "Board"). Mr. McParland and Mr. Wilson replace Cameron Paddock and Rene David who have left Abattis to concentrate on other ventures. Mr. McParland is a Chartered Professional Accountant experienced in multiple industries and geographical locations. As the Company's Chief Financial Officer and Chief Operating Officer, Mr. McParland adds consi...
Abattis Bioceuticals Celebrates Legalization
Abattis Bioceuticals Celebrates Legalization VANCOUVER, British Columbia, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “Company" or "Abattis") (CSE:ATT) (OTC:ATTBF) is pleased to celebrate the legalization of cannabis in Canada. This is a truly a newsworthy day in Canadian history, as we formally recognize the end of cannabis prohibition in our country. Abattis Bioceuticals is proud to recognize all of the activism, efforts and hard work completed by many Canadians throughout the years, culminating in this historical day. Bill C-45, which legalizes the recreational...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.